Last reviewed · How we verify

Vinyl Alcohol Polymer (POLYVINYL ALCOHOL)

discontinued Small molecule

Polyvinyl alcohol works by forming a protective barrier on the surface of the eye to help repair and maintain the tear film.

Polyvinyl alcohol (PVA), also known as polyvinyl alcohol polymer, is a synthetic polymer used in ophthalmic applications. It is used to treat red eye and tear film insufficiency by providing a protective barrier for the eye. PVA is a small molecule modality, but its commercial status and pharmacokinetic properties are not well-documented. It is currently owned by a pharmaceutical company, but the exact details are not publicly available. PVA is FDA-approved for its indicated uses.

At a glance

Generic namePOLYVINYL ALCOHOL
ModalitySmall molecule
Therapeutic areaOphthalmology
Phasediscontinued

Mechanism of action

Imagine your eye's surface is like a delicate skin that needs to be protected and moisturized. Polyvinyl alcohol helps to create a shield that prevents further irritation and damage, allowing the eye to heal and recover. This protective barrier also helps to maintain the balance of the tear film, which is essential for clear vision and eye health.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: